Brief Description
Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers known as Deubiquituinase Targeting Chimeras (DUBTACs). The company’s mission is to use this proprietary technology to solve critical problems in human health by developing next-generation disease therapies against an entire class of previously inaccessible disease-causing proteins. The company spun out of technology that was developed through an academic-industry collaboration between UC Berkeley researchers and Novartis Institutes for BioMedical Research.
Timeline
- 2022. Company founded
Inventors
Dan Nomura, Lydia Boike, Jessica Cestellos Spradlin, Dustin Leard Dovala, Nathaniel Henning, Matthew James Hesse, Gang Liu, Jeffrey McKenna, Melissa Pighetti, Markus Eberhard Schirle, John Tallarico, Carl Ward